Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester

Autor: Piotr Tousty, Magda Fraszczyk-Tousty, Sylwia Dzidek, Hanna Jasiak-Jóźwik, Kaja Michalczyk, Ewa Kwiatkowska, Aneta Cymbaluk-Płoska, Andrzej Torbé, Sebastian Kwiatkowski

Publikováno v: Biomedicines, Vol 11, Iss 6, p 1495 (2023)

Preeclampsia (PE) is a multi-factorial disorder of pregnancy, and it continues to be one of the leading causes of fetal and maternal morbidity and mortality worldwide. Aspirin is universally recommended for high-risk women to reduce preeclampsia risk

Externí odkaz: https://doaj.org/article/efca2f09b1384c25be13d93d9cc0e0b8

Psychological Impact and Women’s Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial

Autor: Ana V. Nikčević, Chiara Sacchi, Claudia Marino, Neil O’Gorman, Liona C. Poon, Kypros H. Nicolaides

Publikováno v: International Journal of Environmental Research and Public Health; Volume 20; Issue 7; Pages: 5418

Objective: This study aims to extend the understanding of the psychological impact of the first-trimester pre-eclampsia (PE) screening on women identified as high risk for preterm PE. We examined the differences between low- vs. high-risk women throu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::281734310d3a9f53b0efa825783548eb

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE

Autor: Nicola Persico, Ranjit Akolekar, Daniel L. Rolnik, Kypros H. Nicolaides, L. C. Poon, M.Y. Tan, S. Cicero, Jacques Jani, C. de Paco Matallana, Mandeep Singh, Walter Plasencia, G. Papaioannou, David Wright, Francisca S. Molina, Argyro Syngelaki, D. Janga, Elena Greco

Publikováno v: Ultrasound in Obstetrics & Gynecology. 52:52-59

OBJECTIVES To examine the effect of first-trimester screening for pre-eclampsia (PE) on the prediction of delivering a small-for-gestational-age (SGA) neonate and the effect of prophylactic use of aspirin on the prevention of SGA. METHODS The data fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ce4c19ee4067763cd042a27f01f97a
https://doi.org/10.1002/uog.19077

Predictive performance of the competing risk model in screening for preeclampsia

Autor: Alan Wright, Argyro Syngelaki, Kypros H. Nicolaides, M.Y. Tan, Neil O'Gorman, David Wright, Liona C. Poon

Publikováno v: Wright, D, Tan, M Y, O’Gorman, N, Poon, L C, Syngelaki, A, Wright, A & Nicolaides, K H 2018, ' Predictive performance of the competing risk model in screening for preeclampsia ', American Journal of Obstetrics and Gynecology . https://doi.org/10.1016/j.ajog.2018.11.1087

Background The established method of screening for preeclampsia is to identify risk factors from maternal demographic characteristics and medical history; in the presence of such factors the patient is classified as high risk and in their absence as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b60fba5e13684736e18620fccd51c25
https://kclpure.kcl.ac.uk/ws/files/102702629/Predictive_performance_of_the_WRIGHT_Firstonline14November2018_GREEN_AAM_CC_BY_NC_ND_.pdf